Franklin Resources’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,239,731
Closed -$18.3M 2415
2022
Q1
$18.3M Sell
1,239,731
-12,411
-1% -$183K 0.01% 878
2021
Q4
$16.6M Sell
1,252,142
-148,317
-11% -$1.96M 0.01% 937
2021
Q3
$24.4M Sell
1,400,459
-55,334
-4% -$966K 0.01% 844
2021
Q2
$34.9M Buy
1,455,793
+168,132
+13% +$4.03M 0.01% 742
2021
Q1
$33.1M Buy
1,287,661
+887,951
+222% +$22.8M 0.01% 727
2020
Q4
$7.59M Buy
399,710
+165,810
+71% +$3.15M ﹤0.01% 1008
2020
Q3
$2.95M Hold
233,900
﹤0.01% 1138
2020
Q2
$2.96M Hold
233,900
﹤0.01% 1075
2020
Q1
$1.79M Sell
233,900
-49,600
-17% -$379K ﹤0.01% 1111
2019
Q4
$5.05M Buy
+283,500
New +$5.05M ﹤0.01% 1010
2016
Q1
Sell
-103,357
Closed -$5.24M 1539
2015
Q4
$5.24M Hold
103,357
﹤0.01% 1121
2015
Q3
$5.17M Sell
103,357
-5,507
-5% -$275K ﹤0.01% 1137
2015
Q2
$10.9M Buy
+108,864
New +$10.9M ﹤0.01% 1023